Subscribe To
Achieve: exciting smoking cessation drug approval could come soon
Efficacy: Phase 3 ORCA-3 trial showed significant efficacy of cytisinicline in smoking cessation, reinf...
May 28, 2023, 4:39 am
Achieve life sciences reports statistically significant smoking cessation benefit for cytisinicline in second, confirmatory phase 3 clinical trial
ORCA-3 demonstrated statistically significant topline results in primary and secondary smoking cessation endpoints for both 6- and 12-week ...
May 23, 2023, 10:00 am
Achieve life sciences says confirmatory late-stage trial of its treatment for quitting smoking achieved positive results
Achieve Life Sciences Inc. ACHV, +12.88% said Tuesday a second confirmatory late-stage trial of its cytisinicl...
May 23, 2023, 6:12 am
Achieve life sciences to announce first quarter 2023 financial results and host conference call and webcast on may 9, 2023
SEATTLE and VANCOUVER, British Columbia, April 26, 2023 (GLOBE NEWSWIRE) -- Achieve Life Sciences, Inc. (NASDAQ: ACHV), a late-stage clinical pharmace...
April 26, 2023, 8:00 am
Achieve life sciences to present at life science innovation northwest 2023 conference
SEATTLE and VANCOUVER, British Columbia, April 14, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceutical c...
April 14, 2023, 12:00 pm
Achieve life sciences: all eyes on phase 3 data for smoking cessation drug
ORCA-2 phase 3 trial was a success where cytisinicline has shown statistically significant improvement ...
January 28, 2023, 11:45 pm
Achieve life sciences announces granting of new hire inducement award
SEATTLE, Wash and VANCOUVER, British Columbia, Jan. 27, 2023 (GLOBE NEWSWIRE) — Achieve Life Sciences, Inc. (Nasdaq: ACHV), a late-stage pharmaceuti...
January 27, 2023, 9:30 pm
Achieve life sciences initiates pivotal trial of cytisinicline for smoking cessation
Achieve Life Sciences Inc (NASDAQ: ACHV) has initiated the screening in the ORCA-3 Phase 3 trial of cytisin...
January 25, 2022, 11:08 am
Achieve life sciences initiates pivotal trial of cytisinicline for smoking cessation
Achieve Life Sciences Inc (NASDAQ: ACHV) has initiated the screening in the ORCA-3 Phase 3 trial of cytisin...
January 25, 2022, 11:08 am
Achieve life sciences initiates pivotal trial of cytisinicline for smoking cessation
Achieve Life Sciences Inc (NASDAQ: ACHV) has initiated the screening in the ORCA-3 Phase 3 trial of cytisin...
January 25, 2022, 11:08 am